Participating in a clinical trial starts with finding a study that matches your health profile, confirming you meet the eligibility criteria, and completing a screening process before enrollment. Most people begin their search on ClinicalTrials.gov, the federal database that lists over 400,000 studies worldwide. The process is more straightforward than many expect, though it does require some research upfront and a clear understanding of what you’re signing up for.
Finding a Trial That Fits
ClinicalTrials.gov is the most comprehensive starting point. When you search, put quotation marks around multi-word conditions (like “breast cancer”) to get exact matches. You can use AND between terms to combine concepts, or NOT before a word to exclude it. These small formatting tricks dramatically improve your results.
The most important filter to set is study status. Change it to “Recruiting and not yet recruiting” to see only trials that are actively looking for participants. You can also filter by location, entering your city, state, or country and adjusting a radius bar to set how far you’re willing to travel. If you want to search within a specific hospital system, the Facility Name filter lets you type a hospital or institution directly.
Beyond ClinicalTrials.gov, many major medical centers maintain their own searchable trial databases. Your doctor or specialist can also refer you to trials relevant to your condition, and some disease-specific organizations (like the American Cancer Society or the Alzheimer’s Association) maintain curated lists.
What Determines Your Eligibility
Every trial has inclusion criteria (characteristics you need to have) and exclusion criteria (characteristics that disqualify you). These exist to protect participants and to ensure the study produces reliable results.
Inclusion criteria typically specify the condition being studied, its severity, and sometimes a specific genetic marker or mutation the treatment targets. Exclusion criteria are often broader. Chronic conditions other than the one being studied can change how you respond to a treatment, so they’re frequently grounds for exclusion. The same goes for taking multiple prescription medications, since drug interactions could complicate results or pose safety risks. In an FDA review of 38 drug trials, more than 60% excluded people based on liver function levels, and 58% excluded based on kidney function.
Pregnant or lactating women and children are often excluded for ethical and safety reasons, though pediatric-specific trials do exist. Older adults face a compounding challenge: even when no age restriction is listed, they’re more likely to have multiple chronic conditions or take several medications, both common exclusion factors. Geographic distance from the trial site is another practical barrier. Some trials require frequent in-person visits, and if you can’t reliably get there, enrollment may not be feasible.
Understanding the Four Phases
Clinical trials for new drugs follow a phased structure, and the phase you join shapes your experience significantly.
- Phase 1 enrolls 20 to 100 people, sometimes healthy volunteers rather than patients, and focuses on safety and dosing. These last several months.
- Phase 2 involves up to several hundred people who have the condition, testing whether the treatment works and monitoring side effects. Duration ranges from several months to two years.
- Phase 3 expands to 300 to 3,000 participants and compares the new treatment against existing standard care or a placebo. These are the longest, typically running one to four years.
- Phase 4 happens after a drug is already approved and tracks long-term effects in several thousand people.
Not all trials follow this structure. Studies of medical devices or behavioral interventions don’t use FDA-defined phases. The trial listing on ClinicalTrials.gov will tell you which phase applies.
The Informed Consent Process
Before you officially enroll, you’ll go through informed consent. This isn’t just signing a form. Federal regulations require the research team to walk you through a detailed document covering several specific points: the purpose of the study, how long your participation will last, what procedures you’ll undergo, which of those procedures are experimental, and what risks or discomforts are foreseeable.
The document must also explain what benefits you might gain (if any), what alternative treatments exist outside the trial, how your medical records will be kept confidential, and who to contact if something goes wrong or you have questions. For trials involving more than minimal risk, it must explain whether compensation or medical treatment is available if you’re injured during the study.
One line in the consent form matters more than any other: participation is voluntary, you can refuse without penalty, and you can withdraw at any time without losing any benefits you’re otherwise entitled to. This is a legal protection, not a courtesy. You are never locked in.
How Participants Are Protected
Every clinical trial involving human subjects must be reviewed and approved by an Institutional Review Board (IRB) before it can begin. An IRB is an independent committee, typically made up of scientists, doctors, and community members, that evaluates the study design, the informed consent documents, and the overall risk to participants. The IRB has full authority to approve a trial, require changes before approving it, or shut it down entirely.
This oversight doesn’t end at approval. IRBs conduct periodic reviews throughout the trial to ensure participant safety is being maintained. If new risks emerge or the study deviates from its approved protocol, the IRB can intervene at any point.
Costs, Compensation, and Insurance
Trial sponsors typically cover the cost of the experimental treatment itself, including the drug or device being tested and any study-specific tests or procedures. Routine medical care you’d receive regardless of the trial, like office visits, standard lab work, or imaging, is generally billed to your insurance.
If you have Medicare, Part A and Part B cover some of these routine costs. You may owe 20% of the Medicare-approved amount for services under Part B, and the standard deductible applies. The exact amount depends on your other insurance, what your doctor charges, and whether they accept Medicare assignment.
Many trials also pay participants for their time. The FDA considers this a recruitment incentive rather than a benefit of the research, and IRBs review payment amounts to make sure they’re reasonable without being coercive. Separately, reimbursement for travel expenses like parking, gas, airfare, and lodging is standard practice and treated differently from compensation. The FDA does not consider travel reimbursement a form of undue influence. Some trials cover both; others cover only one or neither. The listing or study coordinator will clarify this before you commit.
Remote and Decentralized Trials
A growing number of trials now allow you to participate partly or entirely from home. These decentralized trials use telemedicine visits, local labs for blood draws, and digital health tools like wearable monitors or smartphone apps to collect data without requiring you to travel to a central research hospital.
If a trial requires specific technology, the study team often provides it. This might include a tablet for completing daily symptom diaries, a wearable heart monitor, or a blood pressure cuff that transmits readings automatically. When trials allow participants to use their own devices, they’re generally expected to also offer study-provided alternatives so that people without a smartphone or tablet aren’t excluded.
Decentralized trials can reduce the financial and logistical burden of participation considerably, especially for people in rural areas or those who can’t easily take time off work. They’re listed on the same databases as traditional trials, so you can filter for them during your search.
Practical Steps to Get Started
Start by searching ClinicalTrials.gov with your condition and location. Filter for recruiting studies and read through the eligibility criteria of any trials that interest you. Most listings include a contact person or phone number for the research team. Reaching out doesn’t commit you to anything. The initial conversation is simply to determine whether you might be a fit.
If you pass an initial phone screening, you’ll typically be invited for an in-person or virtual screening visit that includes medical tests to confirm eligibility. Only after screening and the full informed consent process would you formally enroll. The entire timeline from first contact to enrollment varies widely, from a few days for simple studies to several weeks for complex ones.
Keep in mind that trial participation can require a real time commitment. Phase 3 trials may involve regular visits over several years. Even shorter studies can require multiple trips to a clinic, at-home monitoring, or keeping detailed symptom logs. Ask the study coordinator for a clear schedule of visits and procedures before you agree, so you know exactly what your weeks will look like.